ANVS
Income statement / Annual
Last year (2024), Annovis Bio, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Annovis Bio, Inc.'s net income was -$24.59 B.
See Annovis Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$20.00 B
|
$38.79 M
|
$16.52 M
|
$8.48 M
|
$3.05 M
|
$776,256.00
|
$111,608.00
|
$273,370.00
|
| General & Administrative Expenses |
$6.70 B
|
$6.24 M
|
$9.00 M
|
$6.06 M
|
$3.59 M
|
$829,366.00
|
$602,329.00
|
$409,063.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$6.70 B
|
$6.24 M
|
$9.00 M
|
$6.06 M
|
$3.59 M
|
$829,366.00
|
$602,329.00
|
$409,063.00
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
-$36,754.00
|
-$1.16 M
|
-$735,075.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$26.69 B
|
$45.04 M
|
$25.51 M
|
$14.50 M
|
$5.48 M
|
$870,547.00
|
$713,937.00
|
$682,433.00
|
| Cost And Expenses |
$0.00
|
$45.04 M
|
$25.51 M
|
$14.50 M
|
$5.48 M
|
$870,547.00
|
$713,937.00
|
$682,433.00
|
| Interest Income |
$331.85 M
|
$667.90 M
|
$182,712.00
|
$13,335.00
|
$47,225.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$47.23 M
|
$0.00
|
$66.00
|
$84.00
|
| Depreciation & Amortization |
$0.00
|
$1.00
|
$25.51 M
|
$14.54 M
|
$6.64 M
|
$1.61 M
|
$713,937.00
|
$682,433.00
|
| EBITDA |
$0.00 |
-$45.04 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$66.00 |
$84.00 |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$0.00
|
-$11.17 M
|
$182,712.00
|
$50,089.00
|
$1.18 M
|
$614,642.00
|
$66.00
|
$84.00
|
| Income Before Tax |
-$24.59 B
|
-$56.20 M
|
-$25.33 M
|
-$14.49 M
|
-$5.46 M
|
-$990,980.00
|
-$713,871.00
|
-$682,349.00
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$24.59 B
|
$0.00
|
-$182,712.00
|
-$50,089.00
|
-$1.20 M
|
-$694,142.00
|
-$132.00
|
-$682,433.00
|
| Net Income |
-$24.59 B
|
-$56.20 M
|
-$25.15 M
|
-$14.44 M
|
-$4.26 M
|
-$296,838.00
|
-$713,871.00
|
-$682,349.00
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-2018.5 |
-6.23 |
-3.08 |
-1.89 |
-0.67 |
-0.066 |
-0.16 |
-0.16 |
| EPS Diluted |
-2009.77 |
-6.23 |
-3.08 |
-1.89 |
-0.67 |
-0.066 |
-0.16 |
-0.16 |
| Weighted Average Shares Out |
$12.18 M
|
$9.02 M
|
$8.16 M
|
$7.63 M
|
$6.31 M
|
$4.50 M
|
$4.40 M
|
$4.39 M
|
| Weighted Average Shares Out Diluted |
$12.24 M
|
$9.02 M
|
$8.16 M
|
$7.63 M
|
$6.31 M
|
$4.50 M
|
$4.40 M
|
$4.39 M
|
| Link |
|
|
|
|
|
|
|
|
